• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression

byWinnie Liu
August 10, 2023
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

Click here to read this study in NEJM.

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

RELATED REPORTS

Psychotherapy identified as most effective treatment for grief

Use of a mobile self-help application is associated with increased self-esteem and quality of life in individuals with intellectual disabilities

2 Minute Medicine Rewind October 13, 2025

Tags: Bipolar DisorderdepressionEscitaloprammood disorder
Previous Post

Wellness Check: Mental Health

Next Post

High-risk patent foramen ovale increases the risk of decompression illness in divers

RelatedReports

Parents often unaware of adolescents’ suicidal thoughts
Psychiatry

Psychotherapy identified as most effective treatment for grief

February 2, 2026
Shared decision-making tool for antidepressants improves patient and physician satisfaction
Chronic Disease

Use of a mobile self-help application is associated with increased self-esteem and quality of life in individuals with intellectual disabilities

January 13, 2026
Weekly Rewinds

2 Minute Medicine Rewind October 13, 2025

January 13, 2026
Parental cannabis use increasing, cigarette use decreasing
Psychiatry

Higher tetrahydrocannabinol exposure may be associated with unfavorable mental health outcomes

August 27, 2025
Next Post
β-blockers linked to improved survival in preserved ejection fraction heart failure

High-risk patent foramen ovale increases the risk of decompression illness in divers

#VisualAbstract:Insulin icodec is more effective than insulin glargine for glycemic control

#VisualAbstract:Insulin icodec is more effective than insulin glargine for glycemic control

#VisualAbstract: Atezolizumab added to cabozantinib does not improve clinical outcomes in patients with metastatic renal cell carcinoma

#VisualAbstract: Atezolizumab added to cabozantinib does not improve clinical outcomes in patients with metastatic renal cell carcinoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early menarche and later menopause are associated with increased ovarian cancer risk
  • A telephone-based intervention reduced loneliness and improved well-being among older adults
  • Propofol is associated with lower mortality in sepsis-associated encephalopathy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.